Latest filing published 04 Oct 2024 for Augmedix, Inc., €12k. Read the official filing
No signal scores available.
Jonathan Hawkins appears in our data through filings on Augmedix, Inc. shares, published by SEC (Form 4). Between 15 May 2024 and 2 October 2024, the trades on record add up to 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 4 October 2024, reports a transaction of €12k in Augmedix, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations